StemRIM StemRIM

Investor Library

StemRIMIR LibraryIR News
All Timely Disclosure Information Financial Results Presentation Materials IR News
May 15, 2026 IR News StemRIM Announces Publication of a Paper on a Physician-Initiated Phase 2 Clinical Trial of Redasemtide (HMGB1 Peptide) for Chronic Liver Disease 
April 7, 2026 IR News
StemRIM Inc. is featured on an international public relations video produced by the Public Relations Office, Cabinet Office.
September 16, 2025 IR News Presentation Materials Financial Results for the Fiscal Year Ended July 31 2025 
June 1, 2023 IR News StemRIM Announces Exhibiting at the “BIO International Convention 2023” and Participating in the “Jefferies 2023 Global Healthcare Conference New York”  
May 16, 2023 IR News StemRIM Announces Publication of Scientific Articles for Stem Cell Gene Therapy (PJ5)